The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
暂无分享,去创建一个
L. Barbeito | R. Maccioni | J. P. Muñoz | L Barbeito | R B Maccioni | J P Muñoz | J. Muñoz
[1] M. Owen,et al. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease , 1999, Nature Genetics.
[2] G. Dawson,et al. β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity , 1995, Cell.
[3] K. Imahori,et al. Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments , 1992, Neuroscience Letters.
[4] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[5] S. Shiojiri,et al. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity , 1988, Nature.
[6] E. Maizels,et al. Estrogen modulates Ca(2+)-independent lipid-stimulated kinase in the rabbit corpus luteum of pseudopregnancy. Identification of luteal estrogen-modulated lipid-stimulated kinase as protein kinase C delta. , 1992, The Journal of biological chemistry.
[7] S. Urban,et al. Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells. , 2001, Neuro-oncology.
[8] L. Thal,et al. Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide , 1993, Nature.
[9] H. Wiśniewski,et al. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.
[10] D. Rees,et al. Crystallographic Analyses of Ion Channels: Lessons and Challenges* , 2000, The Journal of Biological Chemistry.
[11] E. Hirsch. Does oxidative stress participate in nerve cell death in Parkinson's disease? , 1993, European neurology.
[12] S. DeKosky,et al. Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease , 1998, Nature Genetics.
[13] R. Maccioni,et al. A tau-like protein interacts with stress fibers and microtubules in human and rodent cultured cell lines. , 1993, Journal of cell science.
[14] M. Beal,et al. Excitotoxicity and nitric oxide in parkinson's disease pathogenesis , 1998, Annals of neurology.
[15] A. Takashima. Tau protein I is essential for amyloid β-protein iduced neurotoxicity , 1993 .
[16] D. Selkoe,et al. Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.
[17] R. Maccioni,et al. Inhibition of tau phosphorylating protein kinase cdk5 prevents β‐amyloid‐induced neuronal death , 1999, FEBS letters.
[18] Joseph S. Beckman,et al. Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease , 1997, The Journal of Neuroscience.
[19] D. Selkoe,et al. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. , 1994, The Journal of biological chemistry.
[20] M. Farrer,et al. Molecular mapping of alzheimer‐type dementia in Down's syndrome , 1998, Annals of neurology.
[21] Carl W. Cotman,et al. Amino-terminal Deletions Enhance Aggregation of β-Amyloid Peptides in Vitro(*) , 1995, The Journal of Biological Chemistry.
[22] H. Vinters,et al. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. , 1998, The American journal of pathology.
[23] I. Lieberburg,et al. Cellular mechanisms of beta-amyloid production and secretion. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[24] D. Selkoe,et al. Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[25] A. LeBlanc,et al. Amyloid β Peptide of Alzheimer’s Disease Downregulates Bcl-2 and Upregulates Bax Expression in Human Neurons , 1996, The Journal of Neuroscience.
[26] Brian J Cummings,et al. β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease , 1996, Neurobiology of Aging.
[27] C. Behl,et al. Mechanisms of neurodegenerative disorders: Part 2: control of cell death. , 2000, Archives of neurology.
[28] C. Albanese,et al. Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism , 1998 .
[29] A. Parpura-Gill,et al. The inhibitory effects of β-amyloid on glutamate and glucose uptakes by cultured astrocytes , 1997, Brain Research.
[30] J. Simpkins,et al. A novel, synergistic interaction between 17 beta-estradiol and glutathione in the protection of neurons against beta-amyloid 25-35-induced toxicity in vitro. , 1998, Molecular pharmacology.
[31] Sarah Tomlin,et al. Microtechnology: Laying it on thick , 1999, Nature.
[32] B. Strooper,et al. Presenilin Function in APP Processing , 2000, Annals of the New York Academy of Sciences.
[33] C. Pike,et al. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. , 2001, Journal of neurochemistry.
[34] J. Mong,et al. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures , 1994, Neuropharmacology.
[35] S. Fahn,et al. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it , 1992, Annals of neurology.
[36] R. Maccioni,et al. A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons. , 2001, Experimental cell research.
[37] J. Buckwalter,et al. Cognitive deficits of men and women with Alzheimer's disease , 1994, Neurology.
[38] R. Maccioni,et al. Increase in the expression of the neuronal cyclin‐dependent protein kinase cdk‐5 during differentiation of N2A neuroblastoma cells , 2000, Neuroreport.
[39] P. Mcgeer,et al. Up-regulated production and activation of the complement system in Alzheimer's disease brain. , 1999, The American journal of pathology.
[40] H. Wiśniewski,et al. Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments. , 1988, Brain research.
[41] R. Maccioni,et al. Evidence for the Participation of the Neuron-Specific CDK5 Activator P35 during Laminin-Enhanced Axonal Growth , 1998, The Journal of Neuroscience.
[42] D. Selkoe,et al. Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[43] L. Edmonds,et al. CONGENITAL MALFORMATIONS AND VINYL CHLORIDE , 1975, The Lancet.
[44] F. Nicoletti,et al. Protective action of idebenone against excitotoxic degeneration in cultured cortical neurons , 1994, Neuroscience Letters.
[45] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[46] M. Kritzer,et al. Ovarian hormones differentially influence immunoreactivity for dopamine β‐ hydroxylase, choline acetyltransferase, and serotonin in the dorsolateral prefrontal cortex of adult rhesus monkeys , 1999, The Journal of comparative neurology.
[47] L. V. Van Eldik,et al. β-Amyloid Stimulation of Inducible Nitric-oxide Synthase in Astrocytes Is Interleukin-1β- and Tumor Necrosis Factor-α (TNFα)-dependent, and Involves a TNFα Receptor-associated Factor- and NFκB-inducing Kinase-dependent Signaling Mechanism* , 2000, The Journal of Biological Chemistry.
[48] M. Graeber,et al. ORIGINAL ARTICLE Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis , 1997 .
[49] Akira Matsumoto,et al. Synaptogenic action of sex steroids in developing and adult neuroendocrine brain , 1991, Psychoneuroendocrinology.
[50] K. Grzeschik,et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.
[51] D. Selkoe. Presenilins, β-amyloid precursor protein and the molecular basis of Alzheimer's disease , 2001, Clinical Neuroscience Research.
[52] J. Beckman. Oxidative damage and tyrosine nitration from peroxynitrite. , 1996, Chemical research in toxicology.
[53] D. Selkoe,et al. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[54] S. Hoyer,et al. Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease , 1996, Acta neurologica Scandinavica. Supplementum.
[55] J. Coyle,et al. Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.
[56] R. Maccioni,et al. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. , 2001, European journal of biochemistry.
[57] L. Pellegrini,et al. Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-X(L). A potential role in modulating the threshold of cell death. , 1999, The Journal of biological chemistry.
[58] S. Lipton,et al. Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.
[59] K. Ueda,et al. Three types of amyloid protein precursor mRNA in human brain: their differential expression in Alzheimer's disease. , 1988, Biochemical and biophysical research communications.
[60] R. Neve,et al. Alzheimer’s disease: a dysfunction of the amyloid precursor protein 1 1 Published on the World Wide Web on 11 September 2000. , 2000, Brain Research.
[61] P. Löschmann,et al. Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists , 1991, Nature.
[62] P. Kushner,et al. Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis , 1994, Journal of neuroscience research.
[63] D. Pollen,et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.
[64] H. Möller,et al. Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis , 1997, Neurogenetics.
[65] R. Maccioni,et al. Role of microtubule-associated proteins in the control of microtubule assembly. , 1995, Physiological reviews.
[66] M. Mattson. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. , 1997, Physiological reviews.
[67] M. Mattson,et al. Impairment of Glucose and Glutamate Transport and Induction of Mitochondrial Oxidative Stress and Dysfunction in Synaptosomes by Amyloid β‐Peptide: Role of the Lipid Peroxidation Product 4‐Hydroxynonenal , 1997, Journal of neurochemistry.
[68] J S Beckman,et al. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. , 1999, Science.
[69] A. Volterra,et al. Peroxynitrite Inhibits Glutamate Transporter Subtypes (*) , 1996, The Journal of Biological Chemistry.
[70] G. Drewes,et al. Tau domains, phosphorylation, and interactions with microtubules , 1995, Neurobiology of Aging.
[71] J. Ávila,et al. Analysis of the expression, distribution and function of cyclin dependent kinase 5 (cdk5) in developing cerebellar macroneurons. , 1997, Journal of cell science.
[72] J. Valpuesta,et al. Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy. , 1998, The American journal of pathology.
[73] D. Butterfield,et al. Amyloid β Peptide (25–35) Inhibits Na+‐Dependent Glutamate Uptake in Rat Hippocampal Astrocyte Cultures , 1996, Journal of neurochemistry.
[74] K. Imahori,et al. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[75] S. Pimplikar,et al. PAT1, a microtubule-interacting protein, recognizes the basolateral sorting signal of amyloid precursor protein. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[76] I. Merchenthaler,et al. Evidence of the Colocalization of Estrogen Receptor-β mRNA and Estrogen Receptor-α Immunoreactivity in Neurons of the Rat Forebrain. , 1998, Endocrinology.
[77] D. Selkoe,et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.
[78] M. Gurney,et al. Immunocytochemical study on the distribution of nitrotyrosine in the brain of the transgenic mice expressing a human Cu/Zn SOD mutation , 2000, Brain Research.
[79] A. Volterra,et al. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[80] B. Chromy,et al. Amyloid-β peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release , 1998, Brain Research.
[81] L. Tsai,et al. Neurotoxicity induces cleavage of p35 to p25 by calpain , 2000, Nature.
[82] C. Peers,et al. Amyloid β peptides mediate hypoxic augmentation of Ca2+ channels , 2001, Journal of neurochemistry.
[83] A. Matsuno,et al. Modulation of Protein Kinases and Microtubule-associated Proteins and Changes in Ultrastructure in Female Rat Pituitary Cells: Effects of Estrogen and Bromocriptine , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[84] L. Barbeito,et al. Nitric Oxide and Superoxide Contribute to Motor Neuron Apoptosis Induced by Trophic Factor Deprivation , 1998, The Journal of Neuroscience.
[85] C. Cotman,et al. Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain , 1997, Brain Research.
[86] J. Lambert,et al. Association at LRP gene locus with sporadic late-onset Alzheimer's disease , 1998, The Lancet.
[87] A. Takashima,et al. Activation of tau protein kinase I/glycogen synthase kinase-3β by amyloid β peptide (25–35) enhances phosphorylation of tau in hippocampal neurons , 1998, Neuroscience Research.
[88] J. Bolaños,et al. Induction of Nitric Oxide Synthase Inhibits Gap Junction Permeability in Cultured Rat Astrocytes , 1996, Journal of neurochemistry.
[89] G. Cooper,et al. Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway* , 1998, The Journal of Biological Chemistry.
[90] P. Greengard,et al. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. , 1994, The Journal of biological chemistry.
[91] K. Imahori,et al. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. , 1997, Journal of biochemistry.
[92] M. Bukrinsky,et al. Cytokine‐stimulated astrocytes damage human neurons via a nitric oxide mechanism , 1996, Glia.
[93] T. Sunderland,et al. Participation of Presenilin 2 in Apoptosis: Enhanced Basal Activity Conferred by an Alzheimer Mutation , 1996, Science.
[94] W. Markesbery,et al. Electrochemical Analysis of Protein Nitrotyrosine and Dityrosine in the Alzheimer Brain Indicates Region-Specific Accumulation , 1998, The Journal of Neuroscience.
[95] P. Mcgeer,et al. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.
[96] W. Snider,et al. Restricted Expression of G86R Cu/Zn Superoxide Dismutase in Astrocytes Results in Astrocytosis But Does Not Cause Motoneuron Degeneration , 2000, The Journal of Neuroscience.
[97] Richard F. Thompson,et al. 17β-Estradiol Enhances NMDA Receptor-Mediated EPSPs and Long-Term Potentiation , 1999 .
[98] D. Davies,et al. Paired helical filament morphology varies with intracellular location in Alzheimer's disease brain , 1997, Neuroscience Letters.
[99] J. Rothstein,et al. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. , 1992, The New England journal of medicine.
[100] M. Beal,et al. Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase , 1999, Brain Research.
[101] M. Gurney,et al. Reactive astrocytes express nitric oxide synthase in the spinal cord of transgenic mice expressing a human Cu/Zn SOD mutation , 1998, Neuroreport.
[102] K. Imahori,et al. Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells. , 1998, Biochimica et biophysica acta.
[103] R. Katzman.,et al. Senile Dementia of the Alzheimer Type Without Neocortical Neurofibrillary Tangles , 1987, Journal of neuropathology and experimental neurology.
[104] D. Perl,et al. Evidence of neuronal oxidative damage in Alzheimer's disease. , 1996, The American journal of pathology.
[105] Y. Itoyama,et al. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis , 1995, Neuroscience Letters.
[106] R. D. Williams,et al. Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[107] Y. Ando,et al. Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid , 1998, Journal of the Neurological Sciences.
[108] D. Green,et al. The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.
[109] D. Borchelt,et al. ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions , 1997, Neuron.
[110] D. Perl,et al. Protein Nitration in Parkinson's Disease , 1998, Journal of neuropathology and experimental neurology.
[111] M. Goedert,et al. Tau protein pathology in neurodegenerative diseases , 1998, Trends in Neurosciences.
[112] A. Paterson,et al. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. , 1998, JAMA.
[113] C. Cotman,et al. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. , 1994, Journal of immunology.
[114] D. Turnbull,et al. MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE , 1989, The Lancet.
[115] X. Chen,et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease , 1996, Nature.
[116] Steven M. Horvath,et al. Alpha-2 macroglobulin is genetically associated with Alzheimer disease , 1998, Nature Genetics.
[117] R. Rosenberg. The molecular and genetic basis of AD: The end of the beginning , 2000, Neurology.
[118] G. Glenner,et al. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .
[119] E. Hertzberg,et al. Gap junctions: biochemical properties and functional regulation under physiological and toxicological conditions , 1990 .
[120] W. R. Brain. Diseases of the Nervous System , 1892, Buffalo Medical and Surgical Journal.
[121] G. Perry,et al. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[122] L. Thal,et al. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), and apolipoprotein E receptor, with late-onset Alzheimer's disease , 1997, Neurology.
[123] M. Owen,et al. The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease. , 1998, Journal of medical genetics.
[124] L. Goldstein,et al. Axonal Transport of Amyloid Precursor Protein Is Mediated by Direct Binding to the Kinesin Light Chain Subunit of Kinesin-I , 2000, Neuron.
[125] Zi-Jiang Chen,et al. Stimulation of Membrane-Bound Guanylate Cyclase Activity by 17-β Estradiol , 1998 .
[126] L. Tsai,et al. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration , 1999, Nature.
[127] S. Przedborski,et al. Inducible Nitric Oxide Synthase Up‐Regulation in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis , 1999, Journal of neurochemistry.
[128] J. Thompson,et al. Decreased Zinc Affinity of Amyotrophic Lateral Sclerosis‐Associated Superoxide Dismutase Mutants Leads to Enhanced Catalysis of Tyrosine Nitration by Peroxynitrite , 1997, Journal of neurochemistry.
[129] J. Brion,et al. ALZHEIMER'S DISEASE AND TAU PROTEINS , 1986, The Lancet.
[130] D. Selkoe,et al. Cell-surface beta-amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an isoform-dependent manner , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[131] L. Barbeito,et al. Nerve Growth Factor Protects PC12 Cells Against Peroxynitrite‐Induced Apoptosis via a Mechanism Dependent on Phosphatidylinositol 3‐Kinase , 1997, Journal of neurochemistry.
[132] D. Choi,et al. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS , 1994, Neuron.
[133] Cell Death and Diseases of the Nervous System , 1999 .
[134] Boyu Zhao,et al. Neurodegeneration in Alzheimer disease , 1996, Molecular and chemical neuropathology.
[135] S. Przedborski,et al. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[136] B. Katzenellenbogen,et al. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[137] C. Morris,et al. Lack of association of the α2-macroglobulin locus on chromosome 12 in AD , 2000, Neurology.
[138] S. Rabacchi,et al. Caspase-2 Mediates Neuronal Cell Death Induced by β-Amyloid , 2000, The Journal of Neuroscience.
[139] A. Imperato,et al. Glutamate uptake is decreased tardively in the spinal cord of FALS mice , 1998, Neuroreport.
[140] H. Gertz,et al. Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain , 1998, Neuroscience.
[141] C. Cotman,et al. Complement Association with Neurons and β-Amyloid Deposition in the Brains of Aged Individuals with Down Syndrome , 2001, Neurobiology of Disease.
[142] Ted M. Dawson,et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease , 1999, Nature Medicine.
[143] M. Beal,et al. Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[144] J. Trojanowski,et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. , 2000, Science.
[145] E. Mandelkow,et al. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[146] D. Selkoe,et al. Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.
[147] David R. Kaplan,et al. Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt , 1997, Science.
[148] Z. Henderson,et al. Enhancement of (45)Ca(2+) influx and voltage-dependent Ca(2+) channel activity by beta-amyloid-(1-40) in rat cortical synaptosomes and cultured cortical neurons. Modulation by the proinflammatory cytokine interleukin-1beta. , 2000, The Journal of biological chemistry.
[149] Xudong Huang,et al. Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.
[150] R. Maccioni,et al. The protein kinase Cdk5 , 2001 .
[151] L. Tsai,et al. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 , 1994, Nature.
[152] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[153] F. Holsboer,et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. , 1997, Molecular pharmacology.
[154] D. Selkoe,et al. Microtubule-associated protein tau (? ) is a major antigenic component of paired helical filaments in Alzheimer disease , 1987 .